查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631171

脑膜炎诊断测试市场规模、份额、趋势分析报告（按类型、最终用途、地区、细分市场预测），2025 年至 2030 年

Meningitis Diagnostic Testing Market Size, Share & Trends Analysis Report By Type (Latex Agglutination Tests, Lateral Flow Assay), By End Use (Hospitals, Diagnostic Centers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

脑膜炎诊断检测市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球脑膜炎诊断检测市场规模预计到 2030 年将达到 1.559 亿美元，2025 年至 2030 年的复合年增长率为 3.9%。

市场的成长归因于人们对疾病早期诊断意识的不断增强，以及对快速诊断和高精度测试的需求不断增长。此外，政府支持力度加大以减轻疾病负担以及诊断中心数量的增加也是推动市场需求的因素。

感染疾病和爱滋病毒流行的不断增加增加了患脑膜炎的风险，并推动了全球对脑膜炎诊断测试的需求。例如，根据世界卫生组织的数据，2021 年全球有超过 3,840 万人感染爱滋病毒。此外，根据疾病预防控制中心的数据，2020 年美国约有 30,635 人被诊断出感染爱滋病毒。此外，据估计，EV脑膜炎在美国每年导致约30,000至50,000人住院。

因此，这些目标疾病的高发生率正在推动製造商开发精准的诊断解决方案。例如，Cepheid 推出了 Xpert EV，这是一种快速分子体外诊断 EV 测试，可在 2.5 小时内提供结果，且具有最佳灵敏度和特异性。同样，Diagenode Diagnostics 的 M-DiaMult 是一种 PCR-CE-IVD套件，可检测多种细菌感染，包括脑膜炎双球菌。

脑膜炎感染由于其长期影响和高死亡率已成为全球性问题。政府正在积极支持提供先进的诊断测试和治疗方法，以根除脑膜炎。例如，脑膜炎研究基金会和疾病预防控制中心公布了多种医院无法接收的感染疾病的诊断，包括结核病、疟疾和脑膜炎。因此，政府为促进各种感染疾病诊断而采取的措施可能为市场提供有利的成长机会。

此外，医疗保健领域的蓬勃发展和诊断测试技术的不断进步可能为市场提供强劲的成长机会。例如，2022年7月，分子诊断检测领域的领导者Abacus Diagnostica在欧洲市场推出了一种新的快速PCR检测，用于快速识别引起脑炎和脑膜炎的病毒。这种新推出的测试可以让医疗专业人员在 70 分钟内识别出导致脑膜炎最常见的病毒。预计高精度快速检测的采用将在未来几年推动市场成长。

脑膜炎诊断检测市场报告重点

  • 由于 PCR 检测受青睐、灵敏度高且週转时间短，PCR 检测领域在 2024 年占据了最大的市场占有率。
  • 由于各类医疗机构越来越多地采用快速检测，预计横向流动化验将在未来几年继续成为成长最快的领域。
  • 医院部门是基准年最大的收入贡献者，其高收益归因于新诊断技术的普及和医疗保险覆盖范围的扩大。
  • 由于感染疾病负担的激增和技术先进产品的采用不断增加，诊断中心部门预计将见证最快的成长率。
  • 由于该地区投资的增加和正在进行的临床试验，预计亚太地区将在预测期内呈现最快的成长。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 脑膜炎诊断检测市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

4. 脑膜炎诊断检测市场业务分析（按类型）

  • 2024 年及 2030 年各类型市场占有率
  • 类型细分仪表板
  • 2018 年至 2030 年按类型分類的市场规模、预测与趋势分析
  • 乳胶凝集试验
  • 横向流动化验
  • PCR 检测
  • ELISA 检测
  • 文化测试
  • 其他的

5. 脑膜炎诊断检验市场-最终用途业务分析

  • 2024 年和 2030 年按最终用途分類的市场占有率
  • 最终用途细分仪表板
  • 2018 年至 2030 年按最终用途分類的市场规模、预测和趋势分析
  • 医院
  • 诊断中心
  • 其他的

6. 脑膜炎诊断检测市场（按地区划分）、估计值和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 按国家/地区，2018 年至 2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区，2018 年至 2030 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区，2018 年至 2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc
    • Abbott.
    • ELITechGroup
    • Seegene Inc.
    • DiaSorin SpA
    • CERTEST BIOTEC.
    • IMMY.
    • Uniogen Oy
    • BIOMERIEUX
Product Code: GVR-4-68040-009-0

Meningitis Diagnostic Testing Market Growth & Trends:

The global meningitis diagnostic testing market size is expected to reach USD 155.9 million by 2030, according to a new report by Grand View Research, Inc, registering a CAGR of 3.9% from 2025 to 2030. The growth of the market is accredited to the rising awareness among the people about early disease diagnosis and increasing demand for rapid diagnosis coupled with the high accuracy of the test. Moreover, the increasing government support to reduce the burden of disease and the rising number of diagnostic centers are other factors fueling market demand.

The increasing prevalence of infectious diseases, and HIV is increasing the risk of developing meningitis, which is increasing the demand for meningitis diagnostic tests, worldwide. For instance, according to the WHO, over 38.4 million people were living with HIV worldwide in 2021. In addition, according to CDC in 2020, around 30,635 people received HIV diagnoses in the U.S. High number of HIV infections may increase the testing rate for meningitis. Moreover, EV meningitis is estimated to result in around 30,000-50,000 hospitalizations every year in the U.S.

Thus, such a high incidence of target diseases is pushing manufacturers to develop precise diagnostic solutions. For instance, Cepheid offered Xpert EV, a fast molecular in vitro diagnostic EV test, which provides results in 2.5 hours with optimum sensitivity and specificity. Similarly, M-DiaMult of Diagenode Diagnostics is a type of PCR- CE-IVD kit that detects many bacterial infections including Neisseria meningitidis.

Meningitis infection has emerged as a global issue owing to its long-term consequences and high mortality rate. The government is offering active support to provide sophisticated diagnostic tests and treatment regimens to eradicate the disease. For instance, the Meningitis Research Foundation and the CDC offer referral diagnoses for different infectious diseases such as tuberculosis, malaria, and meningitis among others that are not available in hospitals. Thus, such government initiatives to promote the diagnosis of various infectious diseases are likely to offer lucrative growth opportunities for the market.

Furthermore, the surge in the healthcare sector developments and growing technological advancements in diagnostic tests are likely to offer robust growth opportunities for the market. For instance, in July 2022, Abacus Diagnostica, a leader in molecular diagnostic testing, launched a novel rapid PCR test in Europe markets for the quick identification of viruses causing encephalitis and meningitis. This newly launched test allows healthcare professionals to identify the most common virus those causes meningitis in a span of 70 minutes. The introduction of rapid tests with high accuracy is anticipated to propel the market growth in the coming years.

Meningitis Diagnostic Testing Market Report Highlights:

  • PCR assay segment held the largest market share in 2024 owing to a high preference for PCR tests and higher sensitivity and lower turnaround times of the test.
  • Lateral flow assay is expected to be the fastest segment during the coming years due to the increasing adoption of rapid tests at different healthcare facilities.
  • Hospitals segment was the leading revenue contributor during the base year and its high revenue is attributed to increasing access to novel diagnostic technologies and improved healthcare coverage.
  • The diagnostic centers segment is anticipated to exhibit the fastest growth rate owing to the surge in the burden of infectious diseases and the increasing adoption of technologically advanced products.
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to rising investments in the region and ongoing trials in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Meningitis Diagnostic Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Meningitis Diagnostic Testing Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Latex Agglutination Tests
    • 4.4.1. Latex Agglutination Tests Market, 2018 - 2030 (USD Million)
  • 4.5. Lateral Flow Assay
    • 4.5.1. Lateral Flow Assay Market, 2018 - 2030 (USD Million)
  • 4.6. PCR Assay
    • 4.6.1. PCR Assay Market, 2018 - 2030 (USD Million)
  • 4.7. ELISA Tests
    • 4.7.1. ELISA Tests Market, 2018 - 2030 (USD Million)
  • 4.8. Culture Test
    • 4.8.1. Culture Test Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Meningitis Diagnostic Testing Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostic Centers
    • 5.5.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Meningitis Diagnostic Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Canada Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Thermo Fisher Scientific Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Type Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bio-Rad Laboratories, Inc
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Type Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Abbott.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Type Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. ELITechGroup
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Type Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Seegene Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Type Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. DiaSorin S.p.A.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Type Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. CERTEST BIOTEC.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Type Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. IMMY.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Type Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Uniogen Oy
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Type Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. BIOMERIEUX
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Type Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global meningitis diagnostic testing market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 18 Europe meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Germany meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 22 Germany meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 23 France meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 24 France meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Spain meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 28 Spain meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Norway meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 30 Norway meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Sweden meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 34 Sweden meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Japan meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 39 Japan meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 China meningitis diagnostic testing market, by type, 2018-2030 (USD Million)
  • Table 41 China meningitis diagnostic testing market, by end use, 2018-2030 (USD Million)
  • Table 42 India meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 43 India meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Australia meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Australia meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46 South Korea meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 47 South Korea meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Thailand meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Thailand meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Latin America meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 51 Latin America meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 52 Latin America meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Brazil meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Brazil meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Argentina meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 56 Argentina meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 59 Middle East & Africa meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Africa meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Africa meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 64 UAE meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 65 UAE meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Kuwait meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
  • Table 67 Kuwait meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Meningitis diagnostic testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Meningitis diagnostic testing market dynamics
  • Fig. 13 Meningitis diagnostic testing market: Porter's five forces analysis
  • Fig. 14 Meningitis diagnostic testing market: PESTLE analysis
  • Fig. 15 Meningitis diagnostic testing market: Type segment dashboard
  • Fig. 16 Meningitis diagnostic testing market: Type market share analysis, 2024 & 2030
  • Fig. 17 Latex agglutination tests market, 2018 - 2030 (USD Million)
  • Fig. 18 Lateral flow assay market, 2018 - 2030 (USD Million)
  • Fig. 19 PCR assay market, 2018 - 2030 (USD Million)
  • Fig. 20 ELISA tests market, 2018 - 2030 (USD Million)
  • Fig. 21 Culture test market, 2018 - 2030 (USD Million)
  • Fig. 22 Others market, 2018 - 2030 (USD Million)
  • Fig. 23 Meningitis diagnostic testing market: End use segment dashboard
  • Fig. 24 Meningitis diagnostic testing market: End use market share analysis, 2024 & 2030
  • Fig. 25 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 26 Diagnostic centers market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Meningitis diagnostic testing market revenue, by region
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. country dynamics
  • Fig. 32 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada country dynamics
  • Fig. 34 Canada meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico country dynamics
  • Fig. 36 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 38 UK country dynamics
  • Fig. 39 UK meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany country dynamics
  • Fig. 41 Germany meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 42 France country dynamics
  • Fig. 43 France meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy country dynamics
  • Fig. 45 Italy meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain country dynamics
  • Fig. 47 Spain meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway country dynamics
  • Fig. 49 Norway meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD Million
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan country dynamics
  • Fig. 56 Japan meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 57 China country dynamics
  • Fig. 58 China meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 59 India country dynamics
  • Fig. 60 India meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand country dynamics
  • Fig. 66 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil country dynamics
  • Fig. 69 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina country dynamics
  • Fig. 71 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 72 MEA meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa country dynamics
  • Fig. 74 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia country dynamics
  • Fig. 76 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 77 UAE country dynamics
  • Fig. 78 UAE meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait country dynamics
  • Fig. 80 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 81 Company categorization
  • Fig. 82 Company market position analysis
  • Fig. 83 Strategic framework